Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04323137 · ClinicalTrials.gov registry record · NA
Encouraging Flu Vaccination Among High-Risk Patients Identified by ML
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 117,649
- Enrollment target
NCT04323137 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 117,649 participants.
The verdict
NCT04323137, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 117,649 participants
- Enrollment target
Study Summary
The purpose of the current study is to test different interventions to determine the most effective way to promote flu vaccine uptake in a high-risk population identified by an "artificial intelligence" (AI) or machine learning (ML) algorithm. The specific aims are: 1. Evaluate the effect on flu vaccination rates of informing health-system patients who are identified by an ML analysis of EHR data to be at high risk for flu complications that they are at high risk with either (a) no additional explanation, (b) an explanation that this determination comes from an analysis of their medical records, and (c) the additional explanation that an AI or ML algorithm made this determination. 2. Evaluate the effects of the same three interventions on diagnoses of flu in the same patients.
Interventions
- BEHAVIORAL Risk reduction
- BEHAVIORAL Medical records-based recommendation
- BEHAVIORAL Algorithm-based recommendation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117,649 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2021-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04323137
The ClinicalTrials.gov registry entry for NCT04323137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117,649 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Risk reduction is the first listed.
NCT04323137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04323137 about?
NCT04323137 is a clinical study titled "Encouraging Flu Vaccination Among High-Risk Patients Identified by ML". The purpose of the current study is to test different interventions to determine the most effective way to promote flu vaccine uptake in a high-risk population identified by an "artificial intelligence" (AI) or machine learning (ML) algorithm. The specific aims are: 1. Evaluate the effect on flu va...
What is the current status of trial NCT04323137?
This trial is currently completed. It is a NA study. The enrollment target is 117,649 participants. The study started on 2020-09-21. Estimated completion is 2021-09-21.
What interventions are being tested in trial NCT04323137?
The interventions under investigation include: Risk reduction (BEHAVIORAL), Medical records-based recommendation (BEHAVIORAL), Algorithm-based recommendation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04323137?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.